Microbiological Risk Control in Cosmetic Manufacturing: Quality Assurance Practices for Safer Product Release
DOI:
https://doi.org/10.63001/tbs.2025.v20.i04.pp2331-2339Keywords:
microbiological contamination, cosmetic manufacturing,, preservative efficacy testing, GMP compliance,, quality assurance, environmental monitoring, CAPA, challenge testing, clean beauty,, RAPEX, FDA cosmetic safety, risk-based quality managementAbstract
Microbiological contamination is a continuous risk in the cosmetic production industry that can pose a
serious danger to the safety of cosmetic products, product stability and regulatory compliance. The cosmetics
industry worldwide is increasingly adopting preservative-free, natural and water-based products, and end
product testing is clearly inadequate. This synthesis reviews what is known about microbiological risk
control practices and quality assurance (QA) frameworks that can aid in the release of cosmetics that will be
safer.This synthesis presents the peer-reviewed evidence as of October 2025 regarding microbiological risk
control practices and quality assurance (QA) for safer cosmetic product release. Raw materials (42%
bacterial incidence), water systems (35%), equipment surfaces (28%), and personnel (18%) are examined
and preventive control measures like environmental monitoring programs, preservative efficacy testing
(PET), and Good Manufacturing Practice (GMP) based sanitation programs are reviewed. The European
RAPEX database shows that the number of microbiological non-compliance notifications has increased from
8 in 2015 to 49 in 2024, highlighting serious vulnerabilities and deficiencies throughout the system. The
paper also shows that by implementing risk-based QA frameworks the incidence rate of recalls is lowered
by around 70%, the rate of consumer complaints by 86% and the cost of regulatory non-compliance is
reduced from an average of USD 485,000 to USD 37,500 per year. Clean-beauty trends, outsourced
manufacturing and global supply chains are critically assessed as emerging challenges. Together, these
findings have confirmed that proactive science-based microbiological risk management, which includes
Corrective and Preventive Action (CAPA) systems, supplier qualification, and ongoing monitoring, is
critical to the successful and confident release of products and continued consumer trust.
